U.S. stocks dip on Fed stimulus uncertainty; Dow slips 0.33%

Investing.com - U.S. stocks fell on Tuesday as amid growing uncertainty over when the Federal Reserve will announce plans to taper the pace of its USD85 billion in monthly bond purchases, which have support equity prices for over a year.

At the close of U.S. trading, the Dow Jones Industrial Average fell 0.33%, the S&P 500 index fell 0.32%, while the Nasdaq Composite index fell 0.20%.

A surprisingly strong November jobs report sparked talk the Federal Reserve may announce plans to taper the pace of its USD85 billion in monthly bond purchases at its Dec. 17-18 monetary policy meeting.

Friday data revealed that the U.S. economy added 203,000 jobs in November, beating expectations for a 180,000 increase. 

Also on Friday, the preliminary Thomson Reuters/University of Michigan consumer sentiment index increased to 82.5 in December from 75.1 the previous month, far surpassing expectations for a 76.0 reading. 

By Monday, renewed uncertainty as to whether or not the U.S. central bank will wait until early 2014 after reviewing more data before deciding on the fate of its stimulus program sent stock prices falling.

While a decision to wind down asset purchases would signal the economy is improving, it would also take away a monetary crutch that has supported stock prices for over a year now.

Ongoing fiscal impasses in Washington pushed prices down as well.

Leading Dow Jones Industrial Average performers included Goldman Sachs, up 1.22%, Walt Disney, up 0.64%, and UnitedHealth Group, up 0.41%.

The Dow Jones Industrial Average's worst performers included Microsoft, down 1.54%, Coca-Cola, down 1.36%, and Procter & Gamble, down 1.34%.

European indices, meanwhile, finished lower.

After the close of European trade, the EURO STOXX 50 fell 0.76%, France's CAC 40 fell 1.04%, while Germany's DAX 30 fell 0.88%. Meanwhile, in the U.K. the FTSE 100 finished down 0.55%.
 

DISCLOSURE: Information on IntelliTraders should not be seen as a recommendation to trade binary options or forex. IntelliTraders is not licensed nor authorized to provide advice on investing and related matters. Information on the website is not, nor should it be seen as investment advice. Clients without sufficient knowledge should seek individual advice from an authorized source. Binary options and forex trading entails significant risks and there is a chance that clients lose all of their invested money. Past performance is not a guarantee of future returns.

This website is independent of binary brokers featured on it. Before trading with any of the brokers, clients should make sure they understand the risks and check if the broker is licensed and regulated. We recommend choosing a regulated broker. In accordance with FTC guidelines, IntelliTraders has financial relationships with some of the products and services mention on this website, and IntelliTraders may be compensated if consumers choose to click these links in our content and ultimately sign up for them.

IntelliTraders does not accept any liability for loss or damage as a result of reliance on the information contained within this website; this includes education material, price quotes and charts, and analysis. Please be aware of the risks associated with trading the financial markets; never invest more money than you can risk losing. The risks involved in trading binary options are high and may not be suitable for all investors. The IntelliTraders Network is educational material and not trading advice. Trade at your own risk.

© 2025 IntelliTraders, inc. All rights reserved. Privacy Policy Terms & Conditions